162 related articles for article (PubMed ID: 19805116)
1. Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1.
Zhang H; Liu JH; Yang W; Springer T; Shimaoka M; Wang JH
Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18345-50. PubMed ID: 19805116
[TBL] [Abstract][Full Text] [Related]
2. AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.
Shimaoka M; Kim M; Cohen EH; Yang W; Astrof N; Peer D; Salas A; Ferrand A; Springer TA
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13991-6. PubMed ID: 16963559
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1.
Huang L; Shimaoka M; Rondon IJ; Roy I; Chang Q; Po M; Dransfield DT; Ladner RC; Edge AS; Salas A; Wood CR; Springer TA; Cohen EH
J Leukoc Biol; 2006 Oct; 80(4):905-14. PubMed ID: 16888085
[TBL] [Abstract][Full Text] [Related]
4. Conformational stability analyses of alpha subunit I domain of LFA-1 and Mac-1.
Mao D; Lü S; Li N; Zhang Y; Long M
PLoS One; 2011; 6(8):e24188. PubMed ID: 21909384
[TBL] [Abstract][Full Text] [Related]
5. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1.
Ma Q; Shimaoka M; Lu C; Jing H; Carman CV; Springer TA
J Biol Chem; 2002 Mar; 277(12):10638-41. PubMed ID: 11792712
[TBL] [Abstract][Full Text] [Related]
7. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
[TBL] [Abstract][Full Text] [Related]
8. 2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.
Carreño R; Brown WS; Li D; Hernandez JA; Wang Y; Kim TK; Craft JW; Komanduri KV; Radvanyi LG; Hwu P; Molldrem JJ; Legge GB; McIntyre BW; Ma Q
J Biol Chem; 2010 Oct; 285(43):32860-32868. PubMed ID: 20724473
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of monoclonal antibody to integrin alphaL beta2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding.
Tang RH; Tng E; Law SK; Tan SM
J Biol Chem; 2005 Aug; 280(32):29208-16. PubMed ID: 15958383
[TBL] [Abstract][Full Text] [Related]
10. Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug design.
Mahalingam B; Ajroud K; Alonso JL; Anand S; Adair BD; Horenstein AL; Malavasi F; Xiong JP; Arnaout MA
J Immunol; 2011 Dec; 187(12):6393-401. PubMed ID: 22095715
[TBL] [Abstract][Full Text] [Related]
11. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
[TBL] [Abstract][Full Text] [Related]
12. Structural basis and kinetics of force-induced conformational changes of an αA domain-containing integrin.
Xiang X; Lee CY; Li T; Chen W; Lou J; Zhu C
PLoS One; 2011; 6(11):e27946. PubMed ID: 22140490
[TBL] [Abstract][Full Text] [Related]
13. Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1.
Sen M; Koksal AC; Yuki K; Wang J; Springer TA
J Biol Chem; 2018 Apr; 293(17):6565-6577. PubMed ID: 29507098
[TBL] [Abstract][Full Text] [Related]
14. Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site.
Lupher ML; Harris EA; Beals CR; Sui LM; Liddington RC; Staunton DE
J Immunol; 2001 Aug; 167(3):1431-9. PubMed ID: 11466362
[TBL] [Abstract][Full Text] [Related]
15. On the affinity regulation of the metal-ion-dependent adhesion sites in integrins.
San Sebastian E; Mercero JM; Stote RH; Dejaegere A; Cossío FP; Lopez X
J Am Chem Soc; 2006 Mar; 128(11):3554-63. PubMed ID: 16536528
[TBL] [Abstract][Full Text] [Related]
16. I domain of beta 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1.
Randi AM; Hogg N
J Biol Chem; 1994 Apr; 269(17):12395-8. PubMed ID: 7909800
[TBL] [Abstract][Full Text] [Related]
17. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
[TBL] [Abstract][Full Text] [Related]
18. Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation.
Shimaoka M; Xiao T; Liu JH; Yang Y; Dong Y; Jun CD; McCormack A; Zhang R; Joachimiak A; Takagi J; Wang JH; Springer TA
Cell; 2003 Jan; 112(1):99-111. PubMed ID: 12526797
[TBL] [Abstract][Full Text] [Related]
19. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
[TBL] [Abstract][Full Text] [Related]
20. Complex structure of engineered modular domains defining molecular interaction between ICAM-1 and integrin LFA-1.
Kang S; Kim CU; Gu X; Owens RM; van Rijn SJ; Boonyaleepun V; Mao Y; Springer TA; Jin MM
PLoS One; 2012; 7(8):e44124. PubMed ID: 22956999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
